AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0138
-0.0010 (-6.59%)
At close: Feb 3, 2026
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $4.89 million as of February 3, 2026. Its market cap has increased by 801.98% in one year.
Market Cap
4.89M
Enterprise Value
11.67M
Revenue
92.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 9, 2013, AXIM Biotechnologies's market cap has increased from 1.98M to 4.89M, an increase of 146.96%. That is a compound annual growth rate of 7.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 4.89M | 28.50% |
| Dec 31, 2025 | 3.81M | 528.02% |
| Dec 31, 2024 | 605.90K | -86.58% |
| Dec 29, 2023 | 4.52M | -12.57% |
| Dec 30, 2022 | 5.16M | -91.35% |
| Dec 31, 2021 | 59.71M | 10.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NKGen Biotech | 7.84M |
| Synlogic | 7.41M |
| Curative Biotechnology | 7.25M |
| Brainstorm Cell Therapeutics | 6.50M |
| BetterLife Pharma | 5.95M |
| Orgenesis | 5.90M |
| Enzon Pharmaceuticals | 5.86M |
| Bioxytran | 5.34M |